 3',5'-Cyclic-GMP Phosphodiesterases
"3',5'-Cyclic-GMP Phosphodiesterases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes that catalyze the hydrolysis of cyclic GMP to yield guanosine-5'-phosphate.
| Descriptor ID |
D015106
|
| MeSH Number(s) |
D08.811.277.352.640.155 D12.644.360.009 D12.776.476.009
|
| Concept/Terms |
3',5'-Cyclic-GMP Phosphodiesterases- 3',5'-Cyclic-GMP Phosphodiesterases
- 3',5' Cyclic GMP Phosphodiesterases
- Phosphodiesterases, 3',5'-Cyclic-GMP
- 3,5-Cyclic GMP Phosphodiesterase
- 3,5 Cyclic GMP Phosphodiesterase
- GMP Phosphodiesterase, 3,5-Cyclic
- Phosphodiesterase, 3,5-Cyclic GMP
- 3,5-Cyclic GMP 5-Nucleotidohydrolase
- 3,5 Cyclic GMP 5 Nucleotidohydrolase
- 5-Nucleotidohydrolase, 3,5-Cyclic GMP
- GMP 5-Nucleotidohydrolase, 3,5-Cyclic
- 3',5'-Cyclic GMP 5'-Nucleotidohydrolase
- 3',5' Cyclic GMP 5' Nucleotidohydrolase
- 5'-Nucleotidohydrolase, 3',5'-Cyclic GMP
- GMP 5'-Nucleotidohydrolase, 3',5'-Cyclic
- 3',5'-Cyclic GMP Phosphodiesterase
- GMP Phosphodiesterase, 3',5'-Cyclic
- Phosphodiesterase, 3',5'-Cyclic GMP
- 3',5'-Cyclic-GMP Phosphodiesterase
- 3',5' Cyclic GMP Phosphodiesterase
- Phosphodiesterase, 3',5'-Cyclic-GMP
|
Below are MeSH descriptors whose meaning is more general than "3',5'-Cyclic-GMP Phosphodiesterases".
Below are MeSH descriptors whose meaning is more specific than "3',5'-Cyclic-GMP Phosphodiesterases".
This graph shows the total number of publications written about "3',5'-Cyclic-GMP Phosphodiesterases" by people in this website by year, and whether "3',5'-Cyclic-GMP Phosphodiesterases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 | | 1998 | 2 | 0 | 2 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 1 | 1 | 2 | | 2006 | 0 | 1 | 1 | | 2007 | 1 | 0 | 1 | | 2017 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "3',5'-Cyclic-GMP Phosphodiesterases" by people in Profiles.
-
Sakornsakolpat P, McCormack M, Bakke P, Gulsvik A, Make BJ, Crapo JD, Cho MH, Silverman EK. Genome-Wide Association Analysis of Single-Breath DlCO. Am J Respir Cell Mol Biol. 2019 05; 60(5):523-531.
-
Hannah-Shmouni F, Moraitis AG, Romero VV, Faucz FR, Mastroyannis SA, Berthon A, Failor RA, Merino M, Demidowich AP, Stratakis CA. Successful Treatment of Estrogen Excess in Primary Bilateral Macronodular Adrenocortical Hyperplasia with Leuprolide Acetate. Horm Metab Res. 2018 02; 50(2):124-132.
-
Poschet JF, Timmins GS, Taylor-Cousar JL, Ornatowski W, Fazio J, Perkett E, Wilson KR, Yu HD, de Jonge HR, Deretic V. Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol. 2007 Sep; 293(3):L712-9.
-
Collard HR, Anstrom KJ, Schwarz MI, Zisman DA. Sildenafil improves walk distance in idiopathic pulmonary fibrosis. Chest. 2007 Mar; 131(3):897-899.
-
Abman SH. Pulmonary hypertension in older children: new approaches and therapies. Paediatr Respir Rev. 2006; 7 Suppl 1:S177-9.
-
Gali? N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005 Nov 17; 353(20):2148-57.
-
Deruelle P, Grover TR, Abman SH. Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep. Am J Physiol Lung Cell Mol Physiol. 2005 Nov; 289(5):L798-806.
-
Deruelle P, Grover TR, Storme L, Abman SH. Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2005 Apr; 288(4):L727-33.
-
Whitehead CM, Earle KA, Fetter J, Xu S, Hartman T, Chan DC, Zhao TL, Piazza G, Klein-Szanto AJ, Pamukcu R, Alila H, Bunn PA, Thompson WJ. Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival. Mol Cancer Ther. 2003 May; 2(5):479-88.
-
Rice PL, Goldberg RJ, Ray EC, Driggers LJ, Ahnen DJ. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res. 2001 Feb 15; 61(4):1541-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|